- Home
- MBRX vs SOS Comparison
MBRX vs SOS Comparison
Compare MBRX & SOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- SOS
- Stock Information
- Founded
- MBRX 2015
- SOS 2004
- Country
- MBRX United States
- SOS China
- Employees
- MBRX N/A
- SOS N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- SOS Finance: Consumer Services
- Sector
- MBRX Health Care
- SOS Finance
- Exchange
- MBRX Nasdaq
- SOS Nasdaq
- Market Cap
- MBRX 14.7M
- SOS 14.8M
- IPO Year
- MBRX 2016
- SOS 2017
- Fundamental
- Price
- MBRX $0.91
- SOS $5.77
- Analyst Decision
- MBRX Strong Buy
- SOS
- Analyst Count
- MBRX 2
- SOS 0
- Target Price
- MBRX $6.00
- SOS N/A
- AVG Volume (30 Days)
- MBRX 399.4K
- SOS 21.9K
- Earning Date
- MBRX 05-13-2025
- SOS 01-01-0001
- Dividend Yield
- MBRX N/A
- SOS N/A
- EPS Growth
- MBRX N/A
- SOS N/A
- EPS
- MBRX N/A
- SOS N/A
- Revenue
- MBRX N/A
- SOS $111,124,000.00
- Revenue This Year
- MBRX N/A
- SOS N/A
- Revenue Next Year
- MBRX N/A
- SOS N/A
- P/E Ratio
- MBRX N/A
- SOS N/A
- Revenue Growth
- MBRX N/A
- SOS N/A
- 52 Week Low
- MBRX $0.40
- SOS $4.04
- 52 Week High
- MBRX $5.29
- SOS $19.05
- Technical
- Relative Strength Index (RSI)
- MBRX 41.99
- SOS 58.05
- Support Level
- MBRX $1.00
- SOS $4.48
- Resistance Level
- MBRX $1.14
- SOS $7.51
- Average True Range (ATR)
- MBRX 0.08
- SOS 0.48
- MACD
- MBRX -0.00
- SOS 0.18
- Stochastic Oscillator
- MBRX 10.00
- SOS 42.57
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About SOS SOS Limited
SOS Ltd is a multifaceted company that leverages the power of big data to provide marketing solutions, while also participating in the burgeoning fields of blockchain and cryptocurrency operations, as well as commodity trading. Its product offerings are diversified across four main areas: commodity trading, insurance marketing, cryptocurrency mining, and other service. The company has has three reporting segments: Commodity trading, Cryptocurrency mining and Others. Key revenue is generated from Commodity trading.